trb_welcome.jpg

 

The mission of TRB Chemedica Group is to develop innovative and patented pharmaceutical products and medical devices in niche therapeutic areas: rheumatology, ophthalmology and neurology.


Video on Dry Eyeeye_pic.jpg

In recent years the nosology of Dry Eye has greatly changed. Professor Baudouin, MD, PhD from National Ophthalmologiy Hospital XV-XX, Vision Institute of Paris explains through this didactic video the complexity of the Dry Eye disease. Moving beyond the simple name of Dry Eye syndrome, we now consider the condition to be Dry Eye disease, insisting on the lack of tears, the lacrimal inflammation and hyperevaporation leading to self-sustaining loops of neurogenic and palpebral inflammations.

View the video


2012-logo-vismed-gel-rvb.jpg

Enhanced protection in dry eye

VISMED® GEL  is a preservative-free viscoelastic solution for sustained lubrication of the eyes in case of sensations of dryness, burning or ocular fatigue induced by environmental conditions, extended computer screen use, contact lens wear or by ophthalmological screening methods.

VISMED® GEL  is a patented hypotonic formulation that contains both 0.30% sodium hyaluronate, a natural polymer which is also present in the structures of human eyes, and most of the essential ions that are present in natural tears.

VISMED® GEL  is available in boxes of 20 (or 60) reclosable single dose units of 0.45 ml.

2012-packshot_vismed_gel_rgb_72dpi.jpg 
pdf VISMED® GEL leaflet
trb_lock.gif Doctor information
Distributors
trb_contact.gifContacts

News-Events
 
 
  • English